Latest Articles
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com
Published: Jan. 23, 2026, 2:07 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com UK
Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com UK
Published: Jan. 23, 2026, 1:18 p.m.
Phytoestrogens Counter Clomiphene’s Endometrial Effects in IUI - Bioengineer.org
Phytoestrogens Counter Clomiphene’s Endometrial Effects in IUI Bioengineer.org
Published: Jan. 22, 2026, 9:54 p.m.
Phytoestrogens Counter Clomiphene’s Endometrial Effects in IUI - BIOENGINEER.ORG
Phytoestrogens Counter Clomiphene’s Endometrial Effects in IUI BIOENGINEER.ORG
Published: Jan. 22, 2026, 9:54 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology
Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com
Published: Jan. 22, 2026, 4:02 p.m.
Endometrial Ablation Equipment Market Experiences Growth with - openPR.com
Endometrial Ablation Equipment Market Experiences Growth with openPR.com
Published: Jan. 22, 2026, 1:30 p.m.
Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst - Times of India
Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst Times of India
Published: Jan. 21, 2026, 3:17 p.m.
Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery - Cureus
Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery Cureus
Published: Jan. 21, 2026, 1:51 p.m.
Endometrial Cancer Market Poised to Grow from USD 16.89 Billion in 2024 to USD 32.77 Billion by 2035 - openPR.com
Endometrial Cancer Market Poised to Grow from USD 16.89 Billion in 2024 to USD 32.77 Billion by 2035 openPR.com
Published: Jan. 21, 2026, 1:15 p.m.
Link copied to clipboard!